Enabling Technologies and Drug Discovery: Continuous Flow Processes to Discover Novel Antiviral Inhibitors

Risultati finali

Report on Communication activities carried out

List of press releases to local and national press publication on news about the project

Report on Dissemination activities carried out

List of publications of nonconfidential results

Training reports including core scientific training and transferable skills

Description of planed scientific training and transferable skills to be carried out during the project.

Scaffold hopping and database report

Results using 3D pharmacophores programs

Report on VIRO-FLOW Schools

Description of VIROFLOW Schools and actions performed

Annual update of the training plan per ESR

Pubblicazioni

An automated microfluidic platform for the screening and characterization of novel hepatitis B virus capsid assembly modulators

Autori: Tamás Vermes, Mark Kielpinski, Thomas Henkel, Miquel A. Pericàs, Esther Alza, Angelica Corcuera, Helmut Buschmann, Thomas Goldner and Andreas Urban
Pubblicato in: Analytical Methods, Numero 14, 2022, Pagina/e 135-146, ISSN 1759-9660
Editore: Royal Society of Chemistry
DOI: 10.1039/d1ay01227d

Diritti di proprietà intellettuale

NOVEL INDOLIZINE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Numero candidatura/pubblicazione: 20 20061946
Data: 2020-04-29
Candidato/i: AICURIS ANTI-INFECTIVE CURES AG

NOVEL OXALYL PIPERAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Numero candidatura/pubblicazione: 20 20061946
Data: 2020-04-29
Candidato/i: AICURIS ANTI-INFECTIVE CURES AG

Risultati finali

Pubblicazioni

Diritti di proprietà intellettuale

Condividi questa pagina

Scarica